A critical role of hepatic #GABA in the metabolic dysfunction and #hyperphagia of #obesity

Hepatic lipid accumulation is a hallmark of type II diabetes (T2D) associated with hyperinsulinemia, insulin resistance, and hyperphagia. Hepatic synthesis of GABA, catalyzed by GABA-transaminase (GABA-T), is upregulated in obese mice. To assess the role of hepatic GABA production in obesity-induced metabolic and energy dysregulation, we treated mice with two pharmacologic GABA-T inhibitors and knocked …

Continue reading A critical role of hepatic #GABA in the metabolic dysfunction and #hyperphagia of #obesity

#Proton pump inhibitors and risk of #colorectal cancer

To determine whether proton pump inhibitors (PPIs) are associated with an increased risk of colorectal cancer, compared with histamine-2 receptor antagonists (H2RAs). Design The United Kingdom Clinical Practice Research Datalink was used to identify initiators of PPIs and H2RA from 1990 to 2018, with follow-up until 2019. Cox proportional hazards models were fit to estimate …

Continue reading #Proton pump inhibitors and risk of #colorectal cancer